These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32182843)

  • 21. ARTS and small-molecule ARTS mimetics upregulate p53 levels by promoting the degradation of XIAP.
    Abbas R; Hartmann O; Asiss DT; Abbas R; Kagan J; Kim HT; Oren M; Diefenbacher M; Orian A; Larisch S
    Apoptosis; 2024 Aug; 29(7-8):1145-1160. PubMed ID: 38684550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.
    Servida F; Lecis D; Scavullo C; Drago C; Seneci P; Carlo-Stella C; Manzoni L; Polli E; Lambertenghi Deliliers G; Delia D; Onida F
    Invest New Drugs; 2011 Dec; 29(6):1264-75. PubMed ID: 20614162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.
    Sun H; Lu J; Liu L; Yang CY; Wang S
    ACS Chem Biol; 2014 Apr; 9(4):994-1002. PubMed ID: 24521431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/Diablo.
    Edison N; Zuri D; Maniv I; Bornstein B; Lev T; Gottfried Y; Kemeny S; Garcia-Fernandez M; Kagan J; Larisch S
    Cell Death Differ; 2012 Feb; 19(2):356-68. PubMed ID: 21869827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy.
    Obexer P; Ausserlechner MJ
    Front Oncol; 2014; 4():197. PubMed ID: 25120954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).
    Rathore R; McCallum JE; Varghese E; Florea AM; Büsselberg D
    Apoptosis; 2017 Jul; 22(7):898-919. PubMed ID: 28424988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
    Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
    Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.
    Pardo OE; Lesay A; Arcaro A; Lopes R; Ng BL; Warne PH; McNeish IA; Tetley TD; Lemoine NR; Mehmet H; Seckl MJ; Downward J
    Mol Cell Biol; 2003 Nov; 23(21):7600-10. PubMed ID: 14560006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
    Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlike Diablo/smac, Grim promotes global ubiquitination and specific degradation of X chromosome-linked inhibitor of apoptosis (XIAP) and neither cause apoptosis.
    Silke J; Kratina T; Ekert PG; Pakusch M; Vaux DL
    J Biol Chem; 2004 Feb; 279(6):4313-21. PubMed ID: 14570909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smac/Diablo antagonizes ubiquitin ligase activity of inhibitor of apoptosis proteins.
    Creagh EM; Murphy BM; Duriez PJ; Duckett CS; Martin SJ
    J Biol Chem; 2004 Jun; 279(26):26906-14. PubMed ID: 15078891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
    Zhu H; Li Y; Liu Y; Han B
    ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biophysical characterization of the interaction between the full-length XIAP and Smac/DIABLO.
    Polykretis P; Luchinat E
    Biochem Biophys Res Commun; 2021 Sep; 568():180-185. PubMed ID: 34247143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO.
    Morizane Y; Honda R; Fukami K; Yasuda H
    J Biochem; 2005 Feb; 137(2):125-32. PubMed ID: 15749826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
    Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
    Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
    Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.